Duality Advisers, LP Ligand Pharmaceuticals Inc Transaction History

Duality Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 27, 2023	SELL	$65.67 - $77.08 $205,481 - $241,183	-3,129 Reduced 31.87%	6,690 $492,000
Q4 2022 Feb 07, 2023	BUY	$61.72 - $96.74 $606,028 - $949,890	9,819 New	9,819 $655,000
Q2 2022 Aug 08, 2022	BUY	$74.52 - $117.06 $355,907 - $559,078	4,776 New	4,776 $426,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.